Cremieux - Half of America could be on GLP-1s by 2030 (and why peptides are probably overhyped)

Jun 10, 2026 · 0:48:29

Listen to Episode

✨ AI Summary

Researcher Cremieux estimates half of America could be on GLP-1s by 2030.
He notes cost and stigma hinder current GLP-1 uptake.
Cremieux discusses Epic's EHR dashboard as a key adoption indicator.

More from Hims House

Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

Aug 7, 2026 · 0:54:27

🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem

Jul 27, 2026 · 0:59:34

The FDA peptides vote is days away. This insider expects approval

Jul 15, 2026 · 1:01:14

Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share

Jul 7, 2026 · 1:00:30

View all episodes →